Pancreatic Cancer Research

ResearcherOntario Institute for Cancer ResearchActive in the last 2 years

Masoom A. Haider

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7165-8315; OpenAlex author ID A5109392994. Sources: OpenAlex.

Their work

Papers
14 (first author 0, last author 7)
Trials
0
Grants
0
Labs led
1
Collaborators
46
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: 1 paper · 2018: none · 2019: 1 paper · 2020: 2 papers · 2021: 3 papers · 2022: 3 papers · 2023: none · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper

Papers 14

  1. AI-Based Segmentation Reduces the Retrospective Miss Rate of Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1007/s10278-025-01792-0↗
  2. The subclonal footprint of pervasive early dissemination in pancreatic cancer Co-author DOI 10.1101/2025.11.27.690823↗
  3. Canadian National Pancreas Conference 2023: A Review of Multidisciplinary Engagement in Pancreatic Cancer Care. Co-author DOI 10.3390/curroncol31100461↗
  4. Pre-operative radiomics model for prognostication in resectable pancreatic adenocarcinoma with external validation. Last author DOI 10.1007/s00330-021-08314-w↗
  5. Correlation of transcriptional subtypes with a validated CT radiomics score in resectable pancreatic ductal adenocarcinoma. Last author DOI 10.1007/s00330-022-09057-y↗
  6. CT Radiomics and Whole Genome Sequencing in Patients with Pancreatic Ductal Adenocarcinoma: Predictive Radiogenomics Modeling. Co-author DOI 10.3390/cancers14246224↗
  7. Prognostic value of early changes in CT-measured body composition in patients receiving chemotherapy for unresectable pancreatic cancer. Last author DOI 10.1007/s00330-021-07899-6↗
  8. Improving prognostic performance in resectable pancreatic ductal adenocarcinoma using radiomics and deep learning features fusion in CT images. Co-author DOI 10.1038/s41598-021-80998-y↗
  9. Validation of Prognostic Radiomic Features From Resectable Pancreatic Ductal Adenocarcinoma in Patients With Advanced Disease Undergoing Chemotherapy. Last author DOI 10.1177/0846537120968782↗
  10. CNN-based survival model for pancreatic ductal adenocarcinoma in medical imaging. Co-author DOI 10.1186/s12880-020-0418-1↗
  11. Prognostic Value of Transfer Learning Based Features in Resectable Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3389/frai.2020.550890↗
  12. Prognostic Value of CT Radiomic Features in Resectable Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1038/s41598-019-41728-7↗
  13. CT texture features are associated with overall survival in pancreatic ductal adenocarcinoma - a quantitative analysis. Last author DOI 10.1186/s12880-017-0209-5↗
  14. Screening for pancreatic cancer in a high-risk cohort: an eight-year experience. Co-author DOI 10.1007/s11605-011-1781-6↗

Closest collaborators

The 25 strongest of 46 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Steve Gallinger · 12 shared papers, 2012–2026 · strength 1.68
  2. Farzad Khalvati · 7 shared papers, 2017–2021 · strength 0.85
  3. Robert C. Grant · 5 shared papers, 2012–2026 · strength 0.82
  4. Paul Jack Karanicolas · 5 shared papers, 2017–2021 · strength 0.61
  5. Grainne Mary O'Kane · 4 shared papers, 2021–2025 · strength 0.56
  6. Jennifer Jane Knox · 4 shared papers, 2021–2025 · strength 0.56
  7. Yucheng Zhang · 4 shared papers, 2019–2021 · strength 0.53
  8. Andres Alejandro Kohan · 2 shared papers, 2022–2026 · strength 0.51
  9. Emmanuel Salinas-Miranda · 4 shared papers, 2021–2022 · strength 0.51
  10. Gerard M. Healy · 3 shared papers, 2021–2022 · strength 0.39
  11. David Henault · 1 shared paper, 2026 · strength 0.36
  12. Erica S. Tsang · 2 shared papers, 2024–2025 · strength 0.34
  13. George Zogopoulos · 2 shared papers, 2024–2025 · strength 0.34
  14. Ayelet Borgida · 3 shared papers, 2012–2025 · strength 0.33
  15. Barbara T. Grünwald · 2 shared papers, 2022–2025 · strength 0.31
  16. Spring Holter · 2 shared papers, 2012–2025 · strength 0.20
  17. Yuanchang Fang · 1 shared paper, 2025 · strength 0.17
  18. Eugenia Flores Figueroa · 1 shared paper, 2025 · strength 0.17
  19. Yifan Wang · 1 shared paper, 2025 · strength 0.17
  20. Tuan Anh Hoang · 1 shared paper, 2025 · strength 0.17
  21. Michelle Chan‐Seng‐Yue · 1 shared paper, 2025 · strength 0.17
  22. Faiyaz Notta · 1 shared paper, 2025 · strength 0.17
  23. Ravi Ramjeesingh · 1 shared paper, 2024 · strength 0.16
  24. Stacey N. Lee · 1 shared paper, 2024 · strength 0.16
  25. Chloe Cyr · 1 shared paper, 2024 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.